PCE – Pancreatic Cancer Inequality report
Today, Europe has large discrepancies in the incidence and prevalence of pancreatic cancer. These discrepancies are the result of genetic differences, as well as unequal exposure to environmental risk factors, itself the result of cultural differences. Levels of smoking, alcohol consumption, and also diabetes and obesity are different across Europe, which contribute to the variation in the incidence of pancreatic cancer.
Moreover, it seems that pancreatic cancer has been neglected for decades at the political level. National cancer plans seldom mention pancreatic cancer, and research funding is incredibly low for such a lethal cancer.
In this context, this inequality report delivers a comprehensive presentation of the different challenges surrounding pancreatic cancer. This report aims to put pancreatic cancer on the European and national agendas, so that the EU and its Member States can seize the opportunity to tackle one of the deadliest of all common cancers. We at Pancreatic Cancer Europe know it is our duty to inform and take action towards pancreatic cancer control, but we are not able to do it alone.
They endorsed the inequality report:
MEP Soledad Cabezón Ruiz (S&D, Spain)
MEP Françoise Grossetête (EPP, France)
MEP Nathalie Griesbeck (ALDE, France)
MEP Pavel Poc (S&D, Czechia)
MEP Theresa Griffin (S&D, UK)
MEP Marian-Jean Marinescu (EPP, Romania)
MEP Karin Kadenbach (S&D, Austria)
MEP Lieve Wierinck (ALDE, Belgium)
The ‘Fight Pancreatic Cancer’ campaign
The objective of this campaign is to create awareness of Pancreatic Cancer issues through a patient journey, so that it can no longer be referred to as a ‘forgotten cancer’. Discover how reaching out to other people to increase their awareness of early diagnosis through symptoms and on time treatment will result in saved lives.
Discover the link between awareness for early diagnosis through symptoms and treatment on time and how reaching out to other people will result in saved lives.
The objective of this campaign is to create awareness of Pancreatic Cancer issues through a patient journey, so that it can no longer be referred to as a “forgotten cancer”.
Increased awareness by doctors and importantly by a wider audience can drive political and medical change.